Role of pharmacist in managing
pharmaceutical waste
Introduction
Pharmaceutical waste includes any unused, expired, contaminated, damaged, or no longer useful
drug, chemical, or related material generated during the research, development, manufacturing,
dispensing, use, or disposal of medications. This waste encompasses:
Expired drugs (past shelf life and no longer usable)
Unwanted or returned medications from patients
Contaminated products due to improper storage or spillage
Production waste, such as off-spec batches, rejected raw materials, and lab reagents
Packaging waste, like blister packs and vials with residues
Contaminated sharps and devices, such as used syringes, IV sets, and autoinjectors
Waste is further categorized into:
1. Hazardous waste
2. Non-hazardous waste
3. Chemotherapy (chemo) waste
Classification of Pharmaceutical Waste
Hazardous waste is defined as materials that pose direct or potential harm to human health or the
environment, and can exist as liquids, solids, sludges, or gases. It includes:
1. Listed Wastes: Substances specifically mentioned in regulatory lists (F, K, P, U).
Pharmaceutical drugs often appear on the P-list (acutely hazardous) or U-list (toxic) under
the RCRA guidelines.
2. Characteristic Wastes: Defined by traits such as ignitability (D001), corrosivity (D002),
reactivity (D003), and toxicity (D-coded specific to
substance)ResearchGate+4MDPI+4BioMed Central+4PMC.
If waste is neither listed nor characteristic, it is treated as non-hazardous (solid) waste, with disposal
per local regulated medical waste protocols.
Reasons for Waste Generation in Pharmaceutical Manufacturing
Waste in manufacturing arises from both avoidable and unavoidable sources:
Avoidable Waste
These result from inefficiencies, human or operational error, and can be minimized through process
optimization:
Cleaning and sterilization overuse
Equipment failure or poor maintenance
Chemical spills during handling
Rejected intermediates or byproducts
Cross-contamination due to poor segregation
Packaging waste from over-design or misprints
Quality control failures
Human error and operational lapses
Facility/environmental disturbances
Overproduction due to flawed forecasts
Unavoidable Waste
Waste inherent to the process, requiring controls rather than elimination:
Multi-stage chemical synthesis byproducts
Purification and filtration residues of APIs
Spent solvents and chromatography waste
Importance of Listing Toxic Substances Beyond APIs
While APIs are strictly regulated, non-API toxic substances—such as solvents, reagents, catalysts, and
degradation byproducts—carry significant health and environmental risks. These may include heavy
metals, oxidizers, or organic solvents that:
Increase cumulative toxic load and environmental persistence
Pose occupational hazards (inhalation or dermal exposure)
Complicate disposal routes and violate regulatory thresholds
Require specialized segmentation and treatment beyond API-focused
protocolsPMCPMC+[Link]+4Frontiers+4
Role of the Pharmacist
Pharmacists play a central role in minimizing pharmaceutical waste by applying their
expertise in medication use, inventory control, and regulatory compliance. The extent of
waste generation varies among hospital or manufacturing departments, and the
pharmacist’s role adapts accordingly.
1. High Waste Generation Departments
Examples: Oncology (chemotherapy preparation), sterile compounding units, R&D labs,
manufacturing API synthesis.
Pharmacist’s Role:
Implement precise inventory and dosing to reduce expired or unused hazardous drugs.
Enforce hazardous waste segregation (e.g., P-listed antineoplastics vs. trace chemo waste).
Coordinate closed-system transfer devices to limit spills and exposure.
Train staff on safe disposal per EPA/RCRA regulations.
Reference:
Allen, L.V. & Popovich, N.G. (2020). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery
Systems, Wolters Kluwer.
Singh, N., et al. (2019). "Hazardous drug waste management in oncology pharmacy practice."
Journal of Oncology Pharmacy Practice, 25(8), 1945–1952.
2. Medium Waste Generation Departments
Examples: Outpatient pharmacy, inpatient ward stock, quality control labs.
Pharmacist’s Role:
Monitor stock rotation (“first-expire, first-out”) to prevent expiry.
Optimize batch sizes in compounding to match patient demand.
Return unused medicines to suppliers if regulations allow.
Reference:
Prüss, A., Giroult, E., & Rushbrook, P. (2014). Safe management of wastes from health-care
activities (WHO).
3. Low Waste Generation Departments
Examples: Administration, patient counseling units, non-sterile preparation units.
Pharmacist’s Role:
Promote patient education to reduce partial use and self-disposal at home.
Participate in take-back programs for unused medications.
Record and report waste trends for continuous improvement.
Reference:
Diaz, L.F., et al. (2018). "Management of pharmaceutical waste in healthcare facilities."
Waste Management, 71, 510–526.
Minimizing Avoidable Waste
To reduce avoidable waste, pharmacists can apply:
Good Manufacturing Practices (GMP) and staff training
Lean and Six Sigma frameworks to streamline production
Automated and closed-handling systems to reduce spills
Just-in-Time (JIT) inventory and First-Expiry-First-Out (FEFO) systems
Eco-packaging strategies
Ongoing audit and improvement via documented KPIs
References
1. Tripti Shukla et al., “Role of Pharmacist in Pharmaceutical Waste Management,” World J
Environ Biosci, 2017 [Link]+7ResearchGate+[Link]+7PMC
2. Chong et al., “Management of Medicines Wastage...” Frontiers in Medicine, 2022 Frontiers
3. MDPI review: Pharmaceutical Waste Management: A Comprehensive Analysis, highlighting
pharmacy-led waste reduction strategies MDPI
4. )ResearchGate+4MDPI+4BioMed Central+4PMC
5. [Link]
6. PMC+13ResearchGate+13BioMed Central+13
7. Allen, L.V. & Popovich, N.G. (2020). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery
Systems, Wolters Kluwer.
Singh, N., et al. (2019). "Hazardous drug waste management in oncology pharmacy practice."
Journal of Oncology Pharmacy Practice, 25(8), 1945–1952.
8. Prüss, A., Giroult, E., & Rushbrook, P. (2014). Safe management of wastes from health-care
activities (WHO).
9. Diaz, L.F., et al. (2018). "Management of pharmaceutical waste in healthcare facilities."
Waste Management, 71, 510–526.